Skip To Main Content
Abdelrazik Mohamed on Muck Rack

Abdelrazik Mohamed

As seen in: Biomed Central (BMC)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Abdelrazik

Contact Abdelrazik, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Sodium zirconium cyclosilicate versus sodium polystyrene sulfonate for treatment of hyperkalemia in hemodialysis patients: a randomized clinical trial | BMC Nephrology | Full Text

|
By Mohamed Mamdouh, Marwa A. Ahmed, Abdelrazik Mohamed, Islam Ghanem
| Biomed Central (BMC)
References Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975–82. https://doi.org/10.1016/s0140-6736(14)61601-9. Article PubMed Google Scholar Kovesdy CP, Rowan CG, Conrad A, et al. Real-world evaluation of patiromer for the treatment of hyperkalemia in hemodialysis patients. Kidney Int Rep. 2019;4:301–9. https://doi.org/10.1016/j.ekir.2018.10.020. Article PubMed Google Scholar Yusuf AA, Hu Y, Singh B, et al.
Open in Who Shared Issue with article?
See all 1 articles